202 related articles for article (PubMed ID: 30171816)
1. Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
Song W; He D; Chen Y; Yeh CR; Hsu I; Huang Q; Zhang X; Chang LS; Zuo L; Chen J; Doersch KM; Chang C; Li L; Yeh S
Mol Oncol; 2018 Dec; 12(12):2055-2071. PubMed ID: 30171816
[TBL] [Abstract][Full Text] [Related]
2. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract][Full Text] [Related]
3. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
4. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
6. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC.
Gu J; Zhang Y; Han Z; Gao L; Cui J; Sun Y; Niu Y; You B; Huang CP; Chang C; Wang X; Yeh S
Cell Death Dis; 2020 May; 11(5):367. PubMed ID: 32409702
[TBL] [Abstract][Full Text] [Related]
7. Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals.
Song W; Yeh CR; He D; Wang Y; Xie H; Pang ST; Chang LS; Li L; Yeh S
Oncotarget; 2015 Aug; 6(22):19290-304. PubMed ID: 26079540
[TBL] [Abstract][Full Text] [Related]
8. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma.
Liu Y; Qian J; Li X; Chen W; Xu A; Zhao K; Hua Y; Huang Z; Zhang J; Liang C; Su S; Li P; Shao P; Li J; Qin C; Wang Z
Oncotarget; 2016 Dec; 7(49):81410-81422. PubMed ID: 27806310
[TBL] [Abstract][Full Text] [Related]
10. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.
Hsu I; Chuang KL; Slavin S; Da J; Lim WX; Pang ST; O'Brien JH; Yeh S
Carcinogenesis; 2014 Mar; 35(3):651-61. PubMed ID: 24148819
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
12. PPM1A suppresses the proliferation and invasiveness of RCC cells via Smad2/3 signaling inhibition.
Hong Y; Gong L; Yu B; Dong Y
J Recept Signal Transduct Res; 2021 Jun; 41(3):245-254. PubMed ID: 32878540
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network.
Ding J; Yeh CR; Sun Y; Lin C; Chou J; Ou Z; Chang C; Qi J; Yeh S
Oncogene; 2018 Sep; 37(37):5037-5053. PubMed ID: 29789714
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
Liu Y; Shang D
Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
[TBL] [Abstract][Full Text] [Related]
15. ERβ-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma.
Han Z; Zhang Y; Sun Y; Chen J; Chang C; Wang X; Yeh S
Cancer Res; 2018 May; 78(10):2550-2563. PubMed ID: 29490945
[TBL] [Abstract][Full Text] [Related]
16. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
[TBL] [Abstract][Full Text] [Related]
17. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
18. Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.
Tang H; Liao Y; Zhang C; Chen G; Xu L; Liu Z; Fu S; Yu L; Zhou S
Oncol Res; 2014; 22(1):13-20. PubMed ID: 25700354
[TBL] [Abstract][Full Text] [Related]
19. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1.
Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D
Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594
[TBL] [Abstract][Full Text] [Related]
20. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
Jin Z; Gu C; Tian F; Jia Z; Yang J
Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
